Latest Industry Insights
Industry Insight
Learning To Share Can Help Agriculture Endure Now and in the Future
Food is an important part of our everyday lives, and the current COVID-19 pandemic have highlighted just how important having a robust food supply chain is. So much interlocking information goes in to keeping the food production wheels turning. But how do you collate that much diverse data from so many sources, used by so many consumers?
Industry Insight
High Sensitivity Proteomics: Immunopeptidomics
Technology Networks recently spoke with Gary Kruppa, PhD, Vice President of Proteomics, Bruker Daltonics Inc., to learn more about the advancing research area immunopeptidomics, and to discuss the current status of single cell proteomics.
Industry Insight
Proteomics Lends a Hand in the Fight Against COVID-19
Technology Networks spoke with Stephen Williams, Chief Medical Officer of SomaLogic, to learn about how proteomics can contribute to the fight against COVID-19 and the availability of the SomaScan Assay at this critical time.
Industry Insight
Coronavirus and the Need To Go Beyond Testing in a Pandemic
Technology Networks spoke to Phil Groom, commercial director of Bond Digital Health, about the need to go beyond testing in the COVID-19 pandemic, and why data capture is the key to pandemic preparedness and tackling future outbreaks.
Industry Insight
Collaboration To Develop Gene-encoded Antibody Vaccine Against COVID-19 Is Underway
Sorrento Therapeutics Inc. and SmartPharm Therapeutics Inc. recently announced a research and development collaboration in which they will work to develop a next-generation, gene-encoded antibody vaccine for COVID-19. Technology Networks spoke with SmartPharm's CEO Jose Trevejo to learn more about the collaboration and the next steps in the development of the vaccine.
Industry Insight
224-year-old Smallpox Treatment Modified for COVID-19 Candidate Vaccine
Vaccine development is a science over 200 years in the making, but creating a preventative that is effective and safe remains a complex and challenging task. Among the many companies working to create a vaccine for COVID-19 is Tonix Pharmaceuticals. Their pre-clinical candidate vaccine uses a unique platform that sets it apart from other efforts to fight the pandemic. We spoke to Tonix CEO Seth Lederman to find out more.
Industry Insight
Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable
Two teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.
Industry Insight
Maintaining Optimal Blood Volume in COVID-19 Patients
Technology Networks spoke to Michael Feldschuh, CEO, Daxor, to learn more about the importance of maintaining optimal blood volume, how the BVA-100 test can help to measure this, and how clinicians can use the information it provides to guide treatment of COVID-19 patients.
Industry Insight
Developing Antibodies and Antigens for COVID-19 Diagnostics
Technology Networks recently spoke to Dr Andy Lane, Commercial Director, The Native Antigen Company, to learn how SARS-CoV-2 antigens and antibodies can be used to drive the development of COVID-19 diagnostics.
Industry Insight
Which Vaccines Against COVID-19 Are in Human Clinical Trials?
Here, we outline which vaccine candidates against COVID-19 are currently in human clinical trials.
Advertisement